Literature DB >> 2500017

Chronic myeloid leukemia associated with pure red cell aplasia and terminating in promyelocytic transformation.

A Mijović1, Z Rolović, A Novak, L Biljanović-Paunović, D Tomin.   

Abstract

After intermittent treatment with busulphan over a 7-year period for chronic myeloid leukemia (CML) in chronic phase, a 39-year-old female developed leukocytosis in association with pure red cell aplasia (PRCA). Bone marrow examination confirmed erythroid aplasia, and culture revealed a total absence of erythroid progenitor cells. The patient then was treated with azathioprine, corticosteroids, cyclophosphamide, plasma exchange, and cyclosporin A, but she remained erythroblastopenic and transfusion dependent for more than a year, at which time a promyelocytic transformation supervened. The authors propose that this sequence of events, hitherto unreported, is a manifestation of the multistep progression of CML.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500017     DOI: 10.1002/ajh.2830310211

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib.

Authors:  Bishesh Sharma Poudyal; Sampurna Tuladhar; Bishal Gyawali
Journal:  ESMO Open       Date:  2016-05-24

2.  PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia.

Authors:  Stephanie Wolanin; Robert K McCall; Mark J Pettenati; Michael W Beaty; Giovanni Insuasti-Beltran; Bayard L Powell; Stacey S O'Neill
Journal:  Case Rep Hematol       Date:  2020-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.